{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:18:07Z","timestamp":1753355887843,"version":"3.40.3"},"publisher-location":"Singapore","reference-count":142,"publisher":"Springer Nature Singapore","isbn-type":[{"type":"print","value":"9789811956416"},{"type":"electronic","value":"9789811956423"}],"license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-19-5642-3_7","type":"book-chapter","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:44:40Z","timestamp":1669920280000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genome Editing and Diabetic Cardiomyopathy"],"prefix":"10.1007","author":[{"given":"Tyler N.","family":"Kambis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paras K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"issue":"6","key":"7_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595\u2013602","journal-title":"Am J Cardiol"},{"issue":"1","key":"7_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","volume":"11","author":"S Boudina","year":"2010","unstructured":"Boudina S, Abel ED (2010) Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord 11(1):31\u201339","journal-title":"Rev Endocr Metab Disord"},{"key":"7_CR3","first-page":"151","volume":"6","author":"V Chavali","year":"2013","unstructured":"Chavali V, Tyagi SC, Mishra PK (2013) Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes 6:151\u2013160","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"7_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","volume":"115","author":"AI Vinik","year":"2007","unstructured":"Vinik AI, Ziegler D (2007) Diabetic cardiovascular autonomic neuropathy. Circulation 115(3):387\u2013397","journal-title":"Circulation"},{"issue":"2","key":"7_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2337\/dc09-1294","volume":"33","author":"R Pop-Busui","year":"2010","unstructured":"Pop-Busui R (2010) Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 33(2):434\u2013441","journal-title":"Diabetes Care"},{"issue":"4","key":"7_CR6","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pcad.2019.07.003","volume":"62","author":"E Braunwald","year":"2019","unstructured":"Braunwald E (2019) Diabetes, heart failure, and renal dysfunction: the vicious circles. Prog Cardiovasc Dis 62(4):298\u2013302","journal-title":"Prog Cardiovasc Dis"},{"key":"7_CR7","doi-asserted-by":"crossref","unstructured":"Aguilar D (2016) Heart failure, diabetes mellitus, and chronic kidney disease: a clinical conundrum. Circ Heart Fail 9(7)","DOI":"10.1161\/CIRCHEARTFAILURE.116.003316"},{"issue":"1","key":"7_CR8","doi-asserted-by":"publisher","first-page":"15362","DOI":"10.1038\/s41598-018-33837-6","volume":"8","author":"E Pervolaraki","year":"2018","unstructured":"Pervolaraki E, Dachtler J, Anderson RA, Holden AV (2018) The developmental transcriptome of the human heart. Sci Rep 8(1):15362","journal-title":"Sci Rep"},{"issue":"3","key":"7_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.107.687947","volume":"116","author":"T Thum","year":"2007","unstructured":"Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J (2007) MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation 116(3):258\u2013267","journal-title":"Circulation"},{"issue":"7","key":"7_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019667","volume":"10","author":"RO Ramirez Flores","year":"2021","unstructured":"Ramirez Flores RO, Lanzer JD, Holland CH, Leuschner F, Most P, Schultz JH, Levinson RT, Saez-Rodriguez J (2021) Consensus transcriptional landscape of human end-stage heart failure. J Am Heart Assoc 10(7):e019667","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"7_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"issue":"2","key":"7_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136(2):215\u2013233","journal-title":"Cell"},{"issue":"4","key":"7_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s10741-020-10071-9","volume":"26","author":"A Gholaminejad","year":"2021","unstructured":"Gholaminejad A, Zare N, Dana N, Shafie D, Mani A, Javanmard SH (2021) A meta-analysis of microRNA expression profiling studies in heart failure. Heart Fail Rev 26(4):997\u20131021","journal-title":"Heart Fail Rev"},{"key":"7_CR14","first-page":"Unit 19.12","volume":"Chapter 19","author":"B Hall","year":"2009","unstructured":"Hall B, Limaye A, Kulkarni AB (2009) Overview: generation of gene knockout mice. Curr Protoc Cell Biol Chapter 19:Unit 19.12\u201319.12.1-17","journal-title":"Curr Protoc Cell Biol"},{"issue":"1","key":"7_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW 2nd (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106(1):166\u2013175","journal-title":"Circ Res"},{"issue":"1","key":"7_CR16","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1038\/s41467-019-10239-4","volume":"10","author":"M Fernandez-Chacon","year":"2019","unstructured":"Fernandez-Chacon M, Casquero-Garcia V, Luo W, Francesca Lunella F, Ferreira Rocha S, Del Olmo-Cabrera S, Benedito R (2019) iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications. Nat Commun 10(1):2262","journal-title":"Nat Commun"},{"issue":"8","key":"7_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0182828","volume":"12","author":"V Kesherwani","year":"2017","unstructured":"Kesherwani V, Shahshahan HR, Mishra PK (2017) Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing. PLoS One 12(8):e0182828","journal-title":"PLoS One"},{"issue":"1699","key":"7_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.66.1699.84","volume":"66","author":"HJ Muller","year":"1927","unstructured":"Muller HJ (1927) Artificial transmutation of the gene. Science 66(1699):84\u201387","journal-title":"Science"},{"issue":"2723","key":"7_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.105.2723.243","volume":"105","author":"C Auerbach","year":"1947","unstructured":"Auerbach C, Robson JM, Carr JG (1947) The chemical production of mutations. Science 105(2723):243\u2013247","journal-title":"Science"},{"issue":"10","key":"7_CR20","doi-asserted-by":"publisher","first-page":"4951","DOI":"10.1073\/pnas.76.10.4951","volume":"76","author":"S Scherer","year":"1979","unstructured":"Scherer S, Davis RW (1979) Replacement of chromosome segments with altered DNA sequences constructed in vitro. Proc Natl Acad Sci U S A 76(10):4951\u20134955","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/0076-6879(83)01015-0","volume":"101","author":"RJ Rothstein","year":"1983","unstructured":"Rothstein RJ (1983) One-step gene disruption in yeast. Methods Enzymol 101:202\u2013211","journal-title":"Methods Enzymol"},{"issue":"6034","key":"7_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/317230a0","volume":"317","author":"O Smithies","year":"1985","unstructured":"Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS (1985) Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317(6034):230\u2013234","journal-title":"Nature"},{"issue":"3","key":"7_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/0092-8674(86)90463-0","volume":"44","author":"KR Thomas","year":"1986","unstructured":"Thomas KR, Folger KR, Capecchi MR (1986) High frequency targeting of genes to specific sites in the mammalian genome. Cell 44(3):419\u2013428","journal-title":"Cell"},{"issue":"6197","key":"7_CR24","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/336348a0","volume":"336","author":"SL Mansour","year":"1988","unstructured":"Mansour SL, Thomas KR, Capecchi MR (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336(6197):348\u2013352","journal-title":"Nature"},{"issue":"Pt 4","key":"7_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1242\/jcs.074427","volume":"124","author":"JL Youds","year":"2011","unstructured":"Youds JL, Boulton SJ (2011) The choice in meiosis\u2014defining the factors that influence crossover or non-crossover formation. J Cell Sci 124(Pt 4):501\u2013513","journal-title":"J Cell Sci"},{"key":"7_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev-biochem-060713-035418","volume":"83","author":"D Carroll","year":"2014","unstructured":"Carroll D (2014) Genome engineering with targetable nucleases. Annu Rev Biochem 83:409\u2013439","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"7_CR27","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1128\/MCB.15.4.1968","volume":"15","author":"A Choulika","year":"1995","unstructured":"Choulika A, Perrin A, Dujon B, Nicolas JF (1995) Induction of homologous recombination in mammalian chromosomes by using the I-SceI system of Saccharomyces cerevisiae. Mol Cell Biol 15(4):1968\u20131973","journal-title":"Mol Cell Biol"},{"issue":"3","key":"7_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/genetics\/130.3.451","volume":"130","author":"A Plessis","year":"1992","unstructured":"Plessis A, Perrin A, Haber JE, Dujon B (1992) Site-specific recombination determined by I-SceI, a mitochondrial group I intron-encoded endonuclease expressed in the yeast nucleus. Genetics 130(3):451\u2013460","journal-title":"Genetics"},{"issue":"12","key":"7_CR29","first-page":"8096","volume":"14","author":"P Rouet","year":"1994","unstructured":"Rouet P, Smih F, Jasin M (1994) Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol 14(12):8096\u20138106","journal-title":"Mol Cell Biol"},{"issue":"3","key":"7_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/genetics\/122.3.519","volume":"122","author":"N Rudin","year":"1989","unstructured":"Rudin N, Sugarman E, Haber JE (1989) Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae. Genetics 122(3):519\u2013534","journal-title":"Genetics"},{"issue":"4","key":"7_CR31","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ (2012) Playing the end game: DNA double-strand break repair pathway choice. Mol Cell 47(4):497\u2013510","journal-title":"Mol Cell"},{"key":"7_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2021.01.002","volume":"178","author":"S Randhawa","year":"2021","unstructured":"Randhawa S, Sengar S (2021) The evolution and history of gene editing technologies. Prog Mol Biol Transl Sci 178:1\u201362","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"12","key":"7_CR33","doi-asserted-by":"publisher","first-page":"a023754","DOI":"10.1101\/cshperspect.a023754","volume":"8","author":"T Gaj","year":"2016","unstructured":"Gaj T, Sirk SJ, Shui SL, Liu J (2016) Genome-editing technologies: principles and applications. Cold Spring Harb Perspect Biol 8(12):a023754","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"7_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","volume":"31","author":"T Gaj","year":"2013","unstructured":"Gaj T, Gersbach CA, Barbas CF 3rd (2013) ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering. Trends Biotechnol 31(7):397\u2013405","journal-title":"Trends Biotechnol"},{"key":"7_CR35","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.omtn.2019.02.027","volume":"16","author":"SH Khan","year":"2019","unstructured":"Khan SH (2019) Genome-editing technologies: concept, pros, and cons of various genome-editing techniques and bioethical concerns for clinical application. Mol Ther Nucleic Acids 16:326\u2013334","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"7_CR36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD (2010) Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11(9):636\u2013646","journal-title":"Nat Rev Genet"},{"issue":"22","key":"7_CR37","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/gt.2008.145","volume":"15","author":"D Carroll","year":"2008","unstructured":"Carroll D (2008) Progress and prospects: zinc-finger nucleases as gene therapy agents. Gene Ther 15(22):1463\u20131468","journal-title":"Gene Ther"},{"issue":"6","key":"7_CR38","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/j.1460-2075.1985.tb03825.x","volume":"4","author":"J Miller","year":"1985","unstructured":"Miller J, McLachlan AD, Klug A (1985) Repetitive zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J 4(6):1609\u20131614","journal-title":"EMBO J"},{"issue":"3","key":"7_CR39","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1073\/pnas.93.3.1156","volume":"93","author":"YG Kim","year":"1996","unstructured":"Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93(3):1156\u20131160","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"7_CR40","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nbt1125","volume":"23","author":"MH Porteus","year":"2005","unstructured":"Porteus MH, Carroll D (2005) Gene targeting using zinc finger nucleases. Nat Biotechnol 23(8):967\u2013973","journal-title":"Nat Biotechnol"},{"issue":"17","key":"7_CR41","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1093\/nar\/28.17.3361","volume":"28","author":"J Smith","year":"2000","unstructured":"Smith J, Bibikova M, Whitby FG, Reddy AR, Chandrasegaran S, Carroll D (2000) Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res 28(17):3361\u20133369","journal-title":"Nucleic Acids Res"},{"issue":"5007","key":"7_CR42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.2028256","volume":"252","author":"NP Pavletich","year":"1991","unstructured":"Pavletich NP, Pabo CO (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 252(5007):809\u2013817","journal-title":"Science"},{"issue":"6","key":"7_CR43","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1073\/pnas.96.6.2758","volume":"96","author":"DJ Segal","year":"1999","unstructured":"Segal DJ, Dreier B, Beerli RR, Barbas CF 3rd (1999) Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5\u2032-GNN-3\u2032 DNA target sequences. Proc Natl Acad Sci U S A 96(6):2758\u20132763","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"7_CR44","doi-asserted-by":"publisher","first-page":"29466","DOI":"10.1074\/jbc.M102604200","volume":"276","author":"B Dreier","year":"2001","unstructured":"Dreier B, Beerli RR, Segal DJ, Flippin JD, Barbas CF 3rd (2001) Development of zinc finger domains for recognition of the 5\u2032-ANN-3\u2032 family of DNA sequences and their use in the construction of artificial transcription factors. J Biol Chem 276(31):29466\u201329478","journal-title":"J Biol Chem"},{"issue":"3","key":"7_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt796","volume":"21","author":"KH Bae","year":"2003","unstructured":"Bae KH, Kwon YD, Shin HC, Hwang MS, Ryu EH, Park KS, Yang HY, Lee DK, Lee Y, Park J, Kwon HS, Kim HW, Yeh BI, Lee HW, Sohn SH, Yoon J, Seol W, Kim JS (2003) Human zinc fingers as building blocks in the construction of artificial transcription factors. Nat Biotechnol 21(3):275\u2013280","journal-title":"Nat Biotechnol"},{"issue":"11","key":"7_CR46","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1073\/pnas.94.11.5525","volume":"94","author":"Q Liu","year":"1997","unstructured":"Liu Q, Segal DJ, Ghiara JB, Barbas CF 3rd (1997) Design of polydactyl zinc-finger proteins for unique addressing within complex genomes. Proc Natl Acad Sci U S A 94(11):5525\u20135530","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"7_CR47","doi-asserted-by":"publisher","first-page":"14628","DOI":"10.1073\/pnas.95.25.14628","volume":"95","author":"RR Beerli","year":"1998","unstructured":"Beerli RR, Segal DJ, Dreier B, Barbas CF 3rd (1998) Toward controlling gene expression at will: specific regulation of the erbB-2\/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci U S A 95(25):14628\u201314633","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"7_CR48","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1073\/pnas.040552697","volume":"97","author":"RR Beerli","year":"2000","unstructured":"Beerli RR, Dreier B, Barbas CF 3rd (2000) Positive and negative regulation of endogenous genes by designed transcription factors. Proc Natl Acad Sci U S A 97(4):1495\u20131500","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"7_CR49","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1101\/gr.089417.108","volume":"19","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Lee HJ, Kim H, Cho SW, Kim JS (2009) Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res 19(7):1279\u20131288","journal-title":"Genome Res"},{"issue":"5300","key":"7_CR50","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1126\/science.275.5300.657","volume":"275","author":"HA Greisman","year":"1997","unstructured":"Greisman HA, Pabo CO (1997) A general strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites. Science 275(5300):657\u2013661","journal-title":"Science"},{"issue":"7","key":"7_CR51","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/90264","volume":"19","author":"M Isalan","year":"2001","unstructured":"Isalan M, Klug A, Choo Y (2001) A rapid, generally applicable method to engineer zinc fingers illustrated by targeting the HIV-1 promoter. Nat Biotechnol 19(7):656\u2013660","journal-title":"Nat Biotechnol"},{"issue":"21","key":"7_CR52","doi-asserted-by":"publisher","first-page":"12271","DOI":"10.1073\/pnas.2135381100","volume":"100","author":"JA Hurt","year":"2003","unstructured":"Hurt JA, Thibodeau SA, Hirsh AS, Pabo CO, Joung JK (2003) Highly specific zinc finger proteins obtained by directed domain shuffling and cell-based selection. Proc Natl Acad Sci U S A 100(21):12271\u201312276","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"7_CR53","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/gt.2008.96","volume":"15","author":"L Magnenat","year":"2008","unstructured":"Magnenat L, Schwimmer LJ, Barbas CF 3rd (2008) Drug-inducible and simultaneous regulation of endogenous genes by single-chain nuclear receptor-based zinc-finger transcription factor gene switches. Gene Ther 15(17):1223\u20131232","journal-title":"Gene Ther"},{"issue":"2","key":"7_CR54","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2008.06.016","volume":"31","author":"ML Maeder","year":"2008","unstructured":"Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, Unger-Wallace E, Sander JD, Muller-Lerch F, Fu F, Pearlberg J, Gobel C, Dassie JP, Pruett-Miller SM, Porteus MH, Sgroi DC, Iafrate AJ, Dobbs D, McCray PB Jr, Cathomen T, Voytas DF, Joung JK (2008) Rapid \u201copen-source\u201d engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31(2):294\u2013301","journal-title":"Mol Cell"},{"issue":"3","key":"7_CR55","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1101\/gr.143693.112","volume":"23","author":"MS Bhakta","year":"2013","unstructured":"Bhakta MS, Henry IM, Ousterout DG, Das KT, Lockwood SH, Meckler JF, Wallen MC, Zykovich A, Yu Y, Leo H, Xu L, Gersbach CA, Segal DJ (2013) Highly active zinc-finger nucleases by extended modular assembly. Genome Res 23(3):530\u2013538","journal-title":"Genome Res"},{"issue":"6","key":"7_CR56","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nmeth.1994","volume":"9","author":"A Gupta","year":"2012","unstructured":"Gupta A, Christensen RG, Rayla AL, Lakshmanan A, Stormo GD, Wolfe SA (2012) An optimized two-finger archive for ZFN-mediated gene targeting. Nat Methods 9(6):588\u2013590","journal-title":"Nat Methods"},{"issue":"1","key":"7_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nmeth.1542","volume":"8","author":"JD Sander","year":"2011","unstructured":"Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, Curtin SJ, Blackburn JS, Thibodeau-Beganny S, Qi Y, Pierick CJ, Hoffman E, Maeder ML, Khayter C, Reyon D, Dobbs D, Langenau DM, Stupar RM, Giraldez AJ, Voytas DF, Peterson RT, Yeh JR, Joung JK (2011) Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nat Methods 8(1):67\u201369","journal-title":"Nat Methods"},{"issue":"5959","key":"7_CR58","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.1178811","volume":"326","author":"J Boch","year":"2009","unstructured":"Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U (2009) Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326(5959):1509\u20131512","journal-title":"Science"},{"key":"7_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-8944-7_13","volume":"1900","author":"G Hensel","year":"2019","unstructured":"Hensel G, Kumlehn J (2019) Genome engineering using TALENs. Methods Mol Biol 1900:195\u2013215","journal-title":"Methods Mol Biol"},{"key":"7_CR60","doi-asserted-by":"crossref","unstructured":"Naert T, Van Nieuwenhuysen T, Vleminckx K (2017) TALENs and CRISPR\/Cas9 fuel genetically engineered clinically relevant Xenopus tropicalis tumor models. Genesis 55(1\u20132)","DOI":"10.1002\/dvg.23005"},{"issue":"1","key":"7_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/cpsc.104","volume":"52","author":"JM Martin-Fernandez","year":"2020","unstructured":"Martin-Fernandez JM, Fleischer A, Vallejo-Diez S, Palomino E, Sanchez-Gilabert A, Ruiz R, Bejarano Y, Llinas P, Gaya A, Bachiller D (2020) New bicistronic TALENs greatly improve genome editing. Curr Protoc Stem Cell Biol 52(1):e104","journal-title":"Curr Protoc Stem Cell Biol"},{"issue":"6","key":"7_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12491","volume":"51","author":"Y Fang","year":"2018","unstructured":"Fang Y, Cheng Y, Lu D, Gong X, Yang G, Gong Z, Zhu Y, Sang X, Fan S, Zhang J, Zeng F (2018) Treatment of beta(654)-thalassaemia by TALENs in a mouse model. Cell Prolif 51(6):e12491","journal-title":"Cell Prolif"},{"issue":"7","key":"7_CR63","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/pbi.13315","volume":"18","author":"H Bi","year":"2020","unstructured":"Bi H, Fei Q, Li R, Liu B, Xia R, Char SN, Meyers BC, Yang B (2020) Disruption of miRNA sequences by TALENs and CRISPR\/Cas9 induces varied lengths of miRNA production. Plant Biotechnol J 18(7):1526\u20131536","journal-title":"Plant Biotechnol J"},{"issue":"7","key":"7_CR64","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/bit.24890","volume":"110","author":"N Sun","year":"2013","unstructured":"Sun N, Zhao H (2013) Transcription activator-like effector nucleases (TALENs): a highly efficient and versatile tool for genome editing. Biotechnol Bioeng 110(7):1811\u20131821","journal-title":"Biotechnol Bioeng"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-1-4939-2932-0_16","volume":"1338","author":"Y Liu","year":"2016","unstructured":"Liu Y, Zhao H, Cheng CH (2016) Mutagenesis in Xenopus and zebrafish using TALENs. Methods Mol Biol 1338:207\u2013227","journal-title":"Methods Mol Biol"},{"issue":"1","key":"7_CR66","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14(1):49\u201355","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"7_CR67","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/v11050414","volume":"11","author":"SJ Chen","year":"2019","unstructured":"Chen SJ, Chen YC (2019) Potential application of TALENs against murine cytomegalovirus latent infections. Viruses 11(5):414","journal-title":"Viruses"},{"issue":"6","key":"7_CR68","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jgg.2013.03.009","volume":"40","author":"K Chen","year":"2013","unstructured":"Chen K, Gao C (2013) TALENs: customizable molecular DNA scissors for genome engineering of plants. J Genet Genomics 40(6):271\u2013279","journal-title":"J Genet Genomics"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/978-1-4939-8831-0_28","volume":"1874","author":"D Luo","year":"2019","unstructured":"Luo D, Feng K, Zhu Z, Hu W (2019) Generating gene knockout Oryzias latipes and Rice field eel using TALENs method. Methods Mol Biol 1874:489\u2013506","journal-title":"Methods Mol Biol"},{"issue":"374","key":"7_CR70","doi-asserted-by":"publisher","first-page":"eaaj2013","DOI":"10.1126\/scitranslmed.aaj2013","volume":"9","author":"W Qasim","year":"2017","unstructured":"Qasim W, Zhan H, Samarasinghe S, Adams S, Amrolia P, Stafford S, Butler K, Rivat C, Wright G, Somana K, Ghorashian S, Pinner D, Ahsan G, Gilmour K, Lucchini G, Inglott S, Mifsud W, Chiesa R, Peggs KS, Chan L, Farzeneh F, Thrasher AJ, Vora A, Pule M, Veys P (2017) Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells. Sci Transl Med 9(374):eaaj2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"7_CR71","first-page":"243","volume":"17","author":"AQ Yu","year":"2018","unstructured":"Yu AQ, Ding Y, Lu ZY, Hao YZ, Teng ZP, Yan SR, Li DS, Zeng Y (2018) TALENs-mediated homozygous CCR5Delta32 mutations endow CD4+ U87 cells with resistance against HIV1 infection. Mol Med Rep 17(1):243\u2013249","journal-title":"Mol Med Rep"},{"issue":"7","key":"7_CR72","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41477-019-0459-z","volume":"5","author":"T Kazama","year":"2019","unstructured":"Kazama T, Okuno M, Watari Y, Yanase S, Koizuka C, Tsuruta Y, Sugaya H, Toyoda A, Itoh T, Tsutsumi N, Toriyama K, Koizuka N, Arimura SI (2019) Curing cytoplasmic male sterility via TALEN-mediated mitochondrial genome editing. Nat Plants 5(7):722\u2013730","journal-title":"Nat Plants"},{"key":"7_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ibmb.2014.10.003","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Tan A, Xu J, Li Z, Zeng B, Ling L, You L, Chen Y, James AA, Huang Y (2014) Site-specific, TALENs-mediated transformation of Bombyx mori. Insect Biochem Mol Biol 55:26\u201330","journal-title":"Insect Biochem Mol Biol"},{"key":"7_CR74","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1038\/srep03632","volume":"4","author":"Y Feng","year":"2014","unstructured":"Feng Y, Zhang S, Huang X (2014) A robust TALENs system for highly efficient mammalian genome editing. Sci Rep 4:3632","journal-title":"Sci Rep"},{"key":"7_CR75","doi-asserted-by":"crossref","unstructured":"Gan Y, Lin Y, Guo Y, Qi X, Wang Q (2018) Metabolic and genomic characterisation of stress-tolerant industrial Saccharomyces cerevisiae strains from TALENs-assisted multiplex editing. FEMS Yeast Res 18(5)","DOI":"10.1093\/femsyr\/foy045"},{"issue":"10","key":"7_CR76","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1021\/acssynbio.5b00074","volume":"4","author":"G Zhang","year":"2015","unstructured":"Zhang G, Lin Y, Qi X, Li L, Wang Q, Ma Y (2015) TALENs-assisted multiplex editing for accelerated genome evolution to improve yeast phenotypes. ACS Synth Biol 4(10):1101\u20131111","journal-title":"ACS Synth Biol"},{"issue":"1","key":"7_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/genes10010039","volume":"10","author":"E Xia","year":"2019","unstructured":"Xia E, Zhang Y, Cao H, Li J, Duan R, Hu J (2019) TALEN-mediated gene targeting for cystic fibrosis-gene therapy. Genes (Basel) 10(1):39","journal-title":"Genes (Basel)"},{"issue":"5","key":"7_CR78","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/bit.25018","volume":"111","author":"N Sun","year":"2014","unstructured":"Sun N, Zhao H (2014) Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng 111(5):1048\u20131053","journal-title":"Biotechnol Bioeng"},{"issue":"11","key":"7_CR79","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","volume":"24","author":"SR Bacman","year":"2018","unstructured":"Bacman SR, Kauppila JHK, Pereira CV, Nissanka N, Miranda M, Pinto M, Williams SL, Larsson NG, Stewart JB, Moraes CT (2018) MitoTALEN reduces mutant mtDNA load and restores tRNA(ala) levels in a mouse model of heteroplasmic mtDNA mutation. Nat Med 24(11):1696\u20131700","journal-title":"Nat Med"},{"issue":"4","key":"7_CR80","doi-asserted-by":"publisher","first-page":"728","DOI":"10.33594\/000000051","volume":"52","author":"D Meng","year":"2019","unstructured":"Meng D, Han S, Jeong IS, Kim SW (2019) Interleukin 10-secreting MSCs via TALEN-mediated gene editing attenuates left ventricular remodeling after myocardial infarction. Cell Physiol Biochem 52(4):728\u2013741","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"7_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nmeth.1807","volume":"9","author":"M Baker","year":"2012","unstructured":"Baker M (2012) Gene-editing nucleases. Nat Methods 9(1):23\u201326","journal-title":"Nat Methods"},{"issue":"4","key":"7_CR82","first-page":"653","volume":"90","author":"D Carroll","year":"2017","unstructured":"Carroll D (2017) Genome editing: past, present, and future. Yale J Biol Med 90(4):653\u2013659","journal-title":"Yale J Biol Med"},{"issue":"11","key":"7_CR83","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8(11):2281\u20132308","journal-title":"Nat Protoc"},{"issue":"23","key":"7_CR84","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.1111\/febs.13110","volume":"281","author":"Y Ma","year":"2014","unstructured":"Ma Y, Zhang L, Huang X (2014) Genome modification by CRISPR\/Cas9. FEBS J 281(23):5186\u20135193","journal-title":"FEBS J"},{"issue":"4","key":"7_CR85","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/archdischild-2016-310459","volume":"101","author":"M Redman","year":"2016","unstructured":"Redman M, King A, Watson C, King D (2016) What is CRISPR\/Cas9? Arch Dis Child Educ Pract Ed 101(4):213\u2013215","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"7385","key":"7_CR86","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nature10886","volume":"482","author":"B Wiedenheft","year":"2012","unstructured":"Wiedenheft B, Sternberg SH, Doudna JA (2012) RNA-guided genetic silencing systems in bacteria and archaea. Nature 482(7385):331\u2013338","journal-title":"Nature"},{"key":"7_CR87","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-biochem-072911-172315","volume":"82","author":"R Sorek","year":"2013","unstructured":"Sorek R, Lawrence CM, Wiedenheft B (2013) CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 82:237\u2013266","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"7_CR88","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00005-016-0427-5","volume":"65","author":"M Hryhorowicz","year":"2017","unstructured":"Hryhorowicz M, Lipinski D, Zeyland J, Slomski R (2017) CRISPR\/Cas9 immune system as a tool for genome engineering. Arch Immunol Ther Exp (Warsz) 65(3):233\u2013240","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"5962","key":"7_CR89","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.1179555","volume":"327","author":"P Horvath","year":"2010","unstructured":"Horvath P, Barrangou R (2010) CRISPR\/Cas, the immune system of bacteria and archaea. Science 327(5962):167\u2013170","journal-title":"Science"},{"issue":"3","key":"7_CR90","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrg2749","volume":"11","author":"LA Marraffini","year":"2010","unstructured":"Marraffini LA, Sontheimer EJ (2010) CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 11(3):181\u2013190","journal-title":"Nat Rev Genet"},{"issue":"6096","key":"7_CR91","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"issue":"47","key":"7_CR92","doi-asserted-by":"publisher","first-page":"19012","DOI":"10.1073\/pnas.1318481110","volume":"110","author":"X Ren","year":"2013","unstructured":"Ren X, Sun J, Housden BE, Hu Y, Roesel C, Lin S, Liu LP, Yang Z, Mao D, Sun L, Wu Q, Ji JY, Xi J, Mohr SE, Xu J, Perrimon N, Ni JQ (2013) Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9. Proc Natl Acad Sci U S A 110(47):19012\u201319017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7_CR93","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.2507","volume":"31","author":"SW Cho","year":"2013","unstructured":"Cho SW, Kim S, Kim JM, Kim JS (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31(3):230\u2013232","journal-title":"Nat Biotechnol"},{"issue":"6121","key":"7_CR94","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339(6121):819\u2013823","journal-title":"Science"},{"issue":"6121","key":"7_CR95","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823\u2013826","journal-title":"Science"},{"issue":"5","key":"7_CR96","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","volume":"156","author":"H Nishimasu","year":"2014","unstructured":"Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, Ishitani R, Zhang F, Nureki O (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156(5):935\u2013949","journal-title":"Cell"},{"issue":"7519","key":"7_CR97","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature13579","volume":"513","author":"C Anders","year":"2014","unstructured":"Anders C, Niewoehner O, Duerst A, Jinek M (2014) Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513(7519):569\u2013573","journal-title":"Nature"},{"issue":"6275","key":"7_CR98","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1126\/science.aad8282","volume":"351","author":"F Jiang","year":"2016","unstructured":"Jiang F, Taylor DW, Chen JS, Kornfeld JE, Zhou K, Thompson AJ, Nogales E, Doudna JA (2016) Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science 351(6275):867\u2013871","journal-title":"Science"},{"issue":"20","key":"7_CR99","doi-asserted-by":"publisher","first-page":"9584","DOI":"10.1093\/nar\/gkt714","volume":"41","author":"TJ Cradick","year":"2013","unstructured":"Cradick TJ, Fine EJ, Antico CJ, Bao G (2013) CRISPR\/Cas9 systems targeting beta-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41(20):9584\u20139592","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"7_CR100","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31(9):822\u2013826","journal-title":"Nat Biotechnol"},{"issue":"9","key":"7_CR101","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt.2675","volume":"31","author":"P Mali","year":"2013","unstructured":"Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM (2013) CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31(9):833\u2013838","journal-title":"Nat Biotechnol"},{"issue":"6","key":"7_CR102","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154(6):1380\u20131389","journal-title":"Cell"},{"issue":"3","key":"7_CR103","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK (2014) Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32(3):279\u2013284","journal-title":"Nat Biotechnol"},{"issue":"9","key":"7_CR104","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31(9):827\u2013832","journal-title":"Nat Biotechnol"},{"issue":"2","key":"7_CR105","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nbt.3149","volume":"33","author":"B Zetsche","year":"2015","unstructured":"Zetsche B, Volz SE, Zhang F (2015) A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotechnol 33(2):139\u2013142","journal-title":"Nat Biotechnol"},{"issue":"5","key":"7_CR106","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nchembio.1793","volume":"11","author":"KM Davis","year":"2015","unstructured":"Davis KM, Pattanayak V, Thompson DB, Zuris JA, Liu DR (2015) Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol 11(5):316\u2013318","journal-title":"Nat Chem Biol"},{"key":"7_CR107","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.trsl.2015.09.008","volume":"168","author":"N Savic","year":"2016","unstructured":"Savic N, Schwank G (2016) Advances in therapeutic CRISPR\/Cas9 genome editing. Transl Res 168:15\u201321","journal-title":"Transl Res"},{"key":"7_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116636","volume":"232","author":"D Gupta","year":"2019","unstructured":"Gupta D, Bhattacharjee O, Mandal D, Sen MK, Dey D, Dasgupta A, Kazi TA, Gupta R, Sinharoy S, Acharya K, Chattopadhyay D, Ravichandiran V, Roy S, Ghosh D (2019) CRISPR-Cas9 system: a new-fangled dawn in gene editing. Life Sci 232:116636","journal-title":"Life Sci"},{"issue":"4","key":"7_CR109","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.gendis.2016.07.003","volume":"3","author":"L Cai","year":"2016","unstructured":"Cai L, Fisher AL, Huang H, Xie Z (2016) CRISPR-mediated genome editing and human diseases. Genes Dis 3(4):244\u2013251","journal-title":"Genes Dis"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2019.01.017","volume":"447","author":"M Chen","year":"2019","unstructured":"Chen M, Mao A, Xu M, Weng Q, Mao J, Ji J (2019) CRISPR-Cas9 for cancer therapy: opportunities and challenges. Cancer Lett 447:48\u201355","journal-title":"Cancer Lett"},{"issue":"3","key":"7_CR111","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav4324","volume":"5","author":"YL Min","year":"2019","unstructured":"Min YL, Li H, Rodriguez-Caycedo C, Mireault AA, Huang J, Shelton JM, McAnally JR, Amoasii L, Mammen PPA, Bassel-Duby R, Olson EN (2019) CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci Adv 5(3):eaav4324","journal-title":"Sci Adv"},{"key":"7_CR112","doi-asserted-by":"publisher","first-page":"14454","DOI":"10.1038\/ncomms14454","volume":"8","author":"NE Bengtsson","year":"2017","unstructured":"Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS (2017) Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nat Commun 8:14454","journal-title":"Nat Commun"},{"key":"7_CR113","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/5584_2018_331","volume":"1144","author":"S Demirci","year":"2019","unstructured":"Demirci S, Leonard A, Haro-Mora JJ, Uchida N, Tisdale JF (2019) CRISPR\/Cas9 for sickle cell disease: applications, future possibilities, and challenges. Adv Exp Med Biol 1144:37\u201352","journal-title":"Adv Exp Med Biol"},{"issue":"10","key":"7_CR114","doi-asserted-by":"publisher","first-page":"dmm035469","DOI":"10.1242\/dmm.035469","volume":"11","author":"F Tessadori","year":"2018","unstructured":"Tessadori F, Roessler HI, Savelberg SMC, Chocron S, Kamel SM, Duran KJ, van Haelst MM, van Haaften G, Bakkers J (2018) Effective CRISPR\/Cas9-based nucleotide editing in zebrafish to model human genetic cardiovascular disorders. Dis Model Mech 11(10):dmm035469","journal-title":"Dis Model Mech"},{"issue":"7","key":"7_CR115","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/ng.3870","volume":"49","author":"X Liu","year":"2017","unstructured":"Liu X, Yagi H, Saeed S, Bais AS, Gabriel GC, Chen Z, Peterson KA, Li Y, Schwartz MC, Reynolds WT, Saydmohammed M, Gibbs B, Wu Y, Devine W, Chatterjee B, Klena NT, Kostka D, de Mesy Bentley KL, Ganapathiraju MK, Dexheimer P, Leatherbury L, Khalifa O, Bhagat A, Zahid M, Pu W, Watkins S, Grossfeld P, Murray SA, Porter GA Jr, Tsang M, Martin LJ, Benson DW, Aronow BJ, Lo CW (2017) The complex genetics of hypoplastic left heart syndrome. Nat Genet 49(7):1152\u20131159","journal-title":"Nat Genet"},{"issue":"10","key":"7_CR116","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/cr.2016.101","volume":"26","author":"C Xie","year":"2016","unstructured":"Xie C, Zhang YP, Song L, Luo J, Qi W, Hu J, Lu D, Yang Z, Zhang J, Xiao J, Zhou B, Du JL, Jing N, Liu Y, Wang Y, Li BL, Song BL, Yan Y (2016) Genome editing with CRISPR\/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome. Cell Res 26(10):1099\u20131111","journal-title":"Cell Res"},{"issue":"3","key":"7_CR117","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1161\/CIRCRESAHA.118.313225","volume":"123","author":"S Sano","year":"2018","unstructured":"Sano S, Oshima K, Wang Y, Katanasaka Y, Sano M, Walsh K (2018) CRISPR-mediated gene editing to assess the roles of Tet2 and Dnmt3a in clonal hematopoiesis and cardiovascular disease. Circ Res 123(3):335\u2013341","journal-title":"Circ Res"},{"issue":"1","key":"7_CR118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCRESAHA.118.314522","volume":"126","author":"E Schoger","year":"2020","unstructured":"Schoger E, Carroll KJ, Iyer LM, McAnally JR, Tan W, Liu N, Noack C, Shomroni O, Salinas G, Gross J, Herzog N, Doroudgar S, Bassel-Duby R, Zimmermann WH, Zelarayan LC (2020) CRISPR-mediated activation of endogenous gene expression in the postnatal heart. Circ Res 126(1):6\u201324","journal-title":"Circ Res"},{"issue":"43","key":"7_CR119","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1093\/eurheartj\/ehy249","volume":"39","author":"D Mosqueira","year":"2018","unstructured":"Mosqueira D, Mannhardt I, Bhagwan JR, Lis-Slimak K, Katili P, Scott E, Hassan M, Prondzynski M, Harmer SC, Tinker A, Smith JGW, Carrier L, Williams PM, Gaffney D, Eschenhagen T, Hansen A, Denning C (2018) CRISPR\/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur Heart J 39(43):3879\u20133892","journal-title":"Eur Heart J"},{"issue":"5","key":"7_CR120","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/cvr\/cvz250","volume":"116","author":"E Vermersch","year":"2020","unstructured":"Vermersch E, Jouve C, Hulot JS (2020) CRISPR\/Cas9 gene-editing strategies in cardiovascular cells. Cardiovasc Res 116(5):894\u2013907","journal-title":"Cardiovasc Res"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1475-2840-9-49","volume":"9","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC (2010) Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc Diabetol 9:49","journal-title":"Cardiovasc Diabetol"},{"key":"7_CR122","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/978-1-4939-1215-5_22","volume":"1194","author":"V Chavali","year":"2014","unstructured":"Chavali V, Nandi SS, Singh SR, Mishra PK (2014) Generating double knockout mice to model genetic intervention for diabetic cardiomyopathy in humans. Methods Mol Biol 1194:385\u2013400","journal-title":"Methods Mol Biol"},{"key":"7_CR123","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fphys.2016.00093","volume":"7","author":"P Prathipati","year":"2016","unstructured":"Prathipati P, Metreveli N, Nandi SS, Tyagi SC, Mishra PK (2016) Ablation of matrix Metalloproteinase-9 prevents cardiomyocytes contractile dysfunction in diabetics. Front Physiol 7:93","journal-title":"Front Physiol"},{"issue":"6","key":"7_CR124","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","volume":"113","author":"R Kumarswamy","year":"2013","unstructured":"Kumarswamy R, Thum T (2013) Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 113(6):676\u2013689","journal-title":"Circ Res"},{"issue":"2","key":"7_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057800","volume":"8","author":"S Leptidis","year":"2013","unstructured":"Leptidis S, El Azzouzi H, Lok SI, de Weger R, Olieslagers S, Kisters N, Silva GJ, Heymans S, Cuppen E, Berezikov E, De Windt LJ, da Costa MP (2013) A deep sequencing approach to uncover the miRNOME in the human heart. PLoS One 8(2):e57800","journal-title":"PLoS One"},{"issue":"10","key":"7_CR126","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/db16-0023","volume":"65","author":"SS Nandi","year":"2016","unstructured":"Nandi SS, Zheng H, Sharma NM, Shahshahan HR, Patel KP, Mishra PK (2016) Lack of miR-133a decreases contractility of diabetic hearts: a role for novel cross talk between tyrosine aminotransferase and tyrosine hydroxylase. Diabetes 65(10):3075\u20133090","journal-title":"Diabetes"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-0716-1008-4_8","volume":"2224","author":"HR Shahshahan","year":"2021","unstructured":"Shahshahan HR, Kambis TN, Kar S, Yadav SK, Mishra PK (2021) Generating Ins2(+\/\u2212)\/miR-133aTg mice to model miRNA-driven cardioprotection of human diabetic heart. Methods Mol Biol 2224:113\u2013121","journal-title":"Methods Mol Biol"},{"key":"7_CR128","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fcvm.2019.00045","volume":"6","author":"TN Kambis","year":"2019","unstructured":"Kambis TN, Shahshahan HR, Kar S, Yadav SK, Mishra PK (2019) Transgenic expression of miR-133a in the diabetic Akita heart prevents cardiac remodeling and cardiomyopathy. Front Cardiovasc Med 6:45","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"7_CR129","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29(4):341\u2013345","journal-title":"Nat Biotechnol"},{"issue":"7","key":"7_CR130","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/polym13071027","volume":"13","author":"V De Leo","year":"2021","unstructured":"De Leo V, Milano F, Agostiano A, Catucci L (2021) Recent advancements in polymer\/liposome assembly for drug delivery: from surface modifications to hybrid vesicles. Polymers (Basel) 13(7):1027","journal-title":"Polymers (Basel)"},{"key":"7_CR131","first-page":"20","volume":"23","author":"D Chenthamara","year":"2019","unstructured":"Chenthamara D, Subramaniam S, Ramakrishnan SG, Krishnaswamy S, Essa MM, Lin FH, Qoronfleh MW (2019) Therapeutic efficacy of nanoparticles and routes of administration. J Biomed Mater Res 23:20","journal-title":"J Biomed Mater Res"},{"key":"7_CR132","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40824-019-0156-z","volume":"23","author":"YK Sung","year":"2019","unstructured":"Sung YK, Kim SW (2019) Recent advances in the development of gene delivery systems. J Biomed Mater Res 23:8. https:\/\/doi.org\/10.1186\/s40824-019-0156-z","journal-title":"J Biomed Mater Res"},{"key":"7_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27","journal-title":"Adv Biomed Res"},{"issue":"5","key":"7_CR134","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrg1066","volume":"4","author":"CE Thomas","year":"2003","unstructured":"Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4(5):346\u2013358","journal-title":"Nat Rev Genet"},{"issue":"4","key":"7_CR135","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","volume":"31","author":"MF Naso","year":"2017","unstructured":"Naso MF, Tomkowicz B, Perry WL 3rd, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31(4):317\u2013334","journal-title":"BioDrugs"},{"issue":"1","key":"7_CR136","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jchf.2013.09.008","volume":"2","author":"B Greenberg","year":"2014","unstructured":"Greenberg B, Yaroshinsky A, Zsebo KM, Butler J, Felker GM, Voors AA, Rudy JJ, Wagner K, Hajjar RJ (2014) Design of a phase 2b trial of intracoronary administration of AAV1\/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b). JACC Heart Fail 2(1):84\u201392","journal-title":"JACC Heart Fail"},{"issue":"10024","key":"7_CR137","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","volume":"387","author":"B Greenberg","year":"2016","unstructured":"Greenberg B, Butler J, Felker GM, Ponikowski P, Voors AA, Desai AS, Barnard D, Bouchard A, Jaski B, Lyon AR, Pogoda JM, Rudy JJ, Zsebo KM (2016) Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. Lancet 387(10024):1178\u20131186","journal-title":"Lancet"},{"issue":"6","key":"7_CR138","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/gt.2012.19","volume":"19","author":"E Di Pasquale","year":"2012","unstructured":"Di Pasquale E, Latronico MV, Jotti GS, Condorelli G (2012) Lentiviral vectors and cardiovascular diseases: a genetic tool for manipulating cardiomyocyte differentiation and function. Gene Ther 19(6):642\u2013648","journal-title":"Gene Ther"},{"issue":"6","key":"7_CR139","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/mt.2008.61","volume":"16","author":"K Niwano","year":"2008","unstructured":"Niwano K, Arai M, Koitabashi N, Watanabe A, Ikeda Y, Miyoshi H, Kurabayashi M (2008) Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther 16(6):1026\u20131032","journal-title":"Mol Ther"},{"key":"7_CR140","first-page":"81","volume":"22","author":"H Ly","year":"2007","unstructured":"Ly H, Kawase Y, Yoneyama R, Hajjar RJ (2007) Gene therapy in the treatment of heart failure. Physiology (Bethesda) 22:81\u201396","journal-title":"Physiology (Bethesda)"},{"key":"7_CR141","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3389\/fphys.2018.01275","volume":"9","author":"SS Nandi","year":"2018","unstructured":"Nandi SS, Shahshahan HR, Shang Q, Kutty S, Boska M, Mishra PK (2018) MiR-133a mimic alleviates T1DM-induced systolic dysfunction in Akita: an MRI-based study. Front Physiol 9:1275","journal-title":"Front Physiol"},{"issue":"1","key":"7_CR142","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/cvr\/cvv205","volume":"108","author":"MY Rincon","year":"2015","unstructured":"Rincon MY, VandenDriessche T, Chuah MK (2015) Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res 108(1):4\u201320","journal-title":"Cardiovasc Res"}],"container-title":["Advances in Experimental Medicine and Biology","Genome Editing in Cardiovascular and Metabolic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-5642-3_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:52:07Z","timestamp":1669920727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-5642-3_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"ISBN":["9789811956416","9789811956423"],"references-count":142,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-5642-3_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"2 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"No conflict of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}